Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in XGN — Exagen Inc.

CIK 1214717 BOSTON, MA
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$863,290
+$326,719 QoQ
Shares Held
185,654
+3.8% QoQ
Ownership
0.766%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 57 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $16,517,996,286 across 38 Diagnostics & Research names. XGN ranks #33 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 8,382,401 $4,202,600,564
2 DHR
Danaher Corp /De/
 14,280,335 $2,720,118,210
3 IDXX
Idexx Laboratories Inc /De
 2,562,886 $1,349,205,704
4 A
Agilent Technologies, Inc.
 7,595,644 $1,008,929,392
5 WAT
Waters Corp /De/
 2,636,146 $988,660,195
6 IQV
Iqvia Holdings Inc.
 4,454,134 $860,627,771
7 MTD
Mettler Toledo International Inc/
 612,153 $782,031,578
8 NTRA
Natera, Inc.
 2,750,013 $746,491,028

All Filings in XGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $863,290 185,654
2026-03-31 $536,571 178,857
2025-12-31 $1,049,845 172,672
2025-09-30 $1,794,171 163,255
2025-06-30 $1,022,450 146,483
2025-03-31 $361,149 100,599
2024-12-31 $402,033 98,057
2024-09-30 $270,729 87,615
2024-06-30 $159,459 87,615
2024-03-31 $129,716 81,583
2023-12-31 $162,350 81,583
2023-09-30 $197,430 81,583
2023-06-30 $217,500 75,000
2023-03-31 $182,250 75,000
2022-12-31 $180,000 75,000
2022-09-30 $203,702 75,167
2022-06-30 $431,458 75,167
2022-03-31 $1,232,605 153,500
2021-12-31 $1,754,083 150,824
2021-09-30 $2,178,638 160,194
2021-06-30 $2,079,862 138,750
2021-03-31 $1,451,642 82,951
2020-12-31 $1,031,606 78,152
2020-09-30 $835,167 77,045
2020-06-30 $978,875 78,878
2020-03-31 $1,044,085 65,501